Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for children with cholera receiving oral rehydration solution
PACTR202608871780333Phase 2Not yet recruiting
- Sponsor
- Public Interest Science Center
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ondansetron in cholera (2 arms), sponsored by Public Interest Science Center. Primary endpoint: Oral rehydration failure. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
cholera
Beyond the preview
Go deeper on PACTR202608871780333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608871780333.